Benefits and risks of drug industry "sponsorship"
Ziegler, R.
Medizinische Monatsschrift für Pharmazeuten 29(5): 193-194
2006
ISSN/ISBN: 0342-9601 PMID: 16719271 Document Number: 601497
Document emailed within 1 workday
Related Documents
Moncrieff, J.; Thomas, P. 2002: The pharmaceutical industry and disease mongering. Psychiatry should not accept so much commercial sponsorship Bmj 325(7357): 216; Author Reply 216Rosen, B.; Irvine, J.; Ritvo, P.; Shapiro, H.; Stewart, D.; Reynolds, K.; Robinson, G.; Thomas, J.; Neuman, J.; Murphy, J. 1997: The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk Fertility and Sterility 68(1): 90-94
Sorell, T. 1998: Should industry sponsor research? Tobacco company sponsorship discredits medical but not all research Bmj 317(7154): 334
Lazar, E.J.; Banks, D.; Graham, C.; Adams, D.; Rheinstein, P.H.; Gross, M.; Witt, A.M. 1992: Drug company sponsorship of education: the response to the FDA draft concept paper JAMA 268(1): 53-54
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Schomburg, L.; Koehrle, J. 2007: Selenium: benefits and risks MMW Fortschritte der Medizin 149(8): 34-36
Baichwal, R.S. 1988: Benefits of biotechnology to pharmaceutical industry Hindustan Antibiotics Bulletin 30(3-4): 51-53
Williams, R.S. 1992: Benefits and risks of oral contraceptive use Postgraduate Medicine 92(7): 155-7 161-2 168-71
Mofenson, H.C.; Caraccio, T.R. 1986: Benefits/risks of syrup of ipecac Pediatrics 77(4): 551-552
Doyle, V.B. 1995: AZT in pregnant women with HIV: risks and benefits Neonatal Network: Nn 14(2): 62-63
Frankman, O. 1979: Risks and benefits of various contraceptive methods Nordisk Medicin 94(12): 307-311
Collins, R.; Peto, R. 1995: Risks and benefits of calcium antagonists Lancet 346(8980): 961-962
Wyatt, H.V. 1978: Polio immunization: benefits and risks Journal of Family Practice 7(3): 469-474
Brown, K.H.; Hammond, C.B. 1989: The risks and benefits of oral contraceptives Advances in Internal Medicine 34: 285-305
Frankman, O. 1979: Risks and benefits of various contraceptive methods Nordisk Medicin 94(12): 307-311
Ovalle, F.; Fernando, O.-B.úm.J. 2002: Thiazolidinediones: a review of their benefits and risks Southern Medical Journal 95(10): 1188-1194
Saraghi, M.; Badner, V.M.; Golden, L.R.; Hersh, E.V. 2013: Propofol: an overview of its risks and benefits Compendium of Continuing Education in Dentistry 34(4): 252-258
Hassed, C. 1999: The risks and benefits of complementary medicine Australian Family Physician 28(7): 732-733
Axelsson, I. 1981: Analysis of risks, costs and benefits Health Physics 40(2): 255-257
Haider, Z.; D'Souza, R. 2009: Non-contraceptive benefits and risks of contraception Best Practice and Research. Clinical Obstetrics and Gynaecology 23(2): 249-262